Publications by authors named "Tatiana Cano Barbadilla"
Diagnostics (Basel)
November 2024
Article Synopsis
- Bladder cancer (BC) is complex and diverse, posing challenges in predicting outcomes and choosing effective treatments, with molecular subtyping being a promising approach but facing practical limitations due to costs and complexity.
- Immunohistochemistry (IHC) is discussed as a potential simpler alternative to molecular methods for classifying BC, focusing on cytokeratin expression patterns to identify subtypes like basal and luminal types, especially in less studied non-muscle-invasive cases.
- The review emphasizes the need for standardized IHC markers and protocols to ensure broader application in clinical settings, while recognizing ongoing challenges and the need for more research to improve diagnostic processes and patient outcomes.
